FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and high-risk individuals. While the FDA met to decide if vaccine formulas should change for fall 2025,

We have to admit to ourselves that America is deeply divided on the policy issue of repeat COVID-19 vaccine doses or boosters,” Dr. Vinay Prasad, FDA’s new highest-ranking vaccines official, recently stated in a video published by the agency.

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the vaccine’s effectiveness for people who are otherwise healthy.

The FDA’s new approach to boosters could mean that kids will no longer be able to get vaccinated against the disease to begin with.

We want to know more about what these products are doing,” said Dr. Vinay Prasad during a recent FDA livestreamed presentation. This statement comes amidst a significant shift in the U.S. Food and Drug Administration’s (FDA) policy on Covid-19 booster shots.

Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for approving future Covid-19 vaccines that he feels will counteract existing “dogma.”

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

Høeg has been skeptical of the safety and value of some vaccines and mandates, raising questions about her approach at the FDA.